Introduction
Soluble monoclonal antibodies (MAb) directed at CD3 induce accessory cell (AC)' dependent T cell proliferation (1, 2) . One role of the AC is to bind the anti-CD3 MAb by Fc receptors 1 . Abbreviations used in this paper: AC, accessory cell; AO, acridine orange; APC, antigen presenting cell; GaMIg, goat anti-mouse immunoglobulin; MHC, major histocompatibility complex; Mo, monocytes; NHS, normal human serum. and thus create a matrix to cross-link anti-CD3 bound CD3 molecules (3, 4) . In addition, AC promote anti-CD3 induced T cell proliferation through AC-T cell interactions involving a variety of AC and T cell surface proteins including CDl la (LFA-1), and class I and II major histocompatibility complex (MHC) encoded gene products (5) . The exact role of these interactions is not completely understood. One possibility, however, is that the AC provides a cellular matrix to cross-link a variety of T cell surface molecules and that cross-linking these surface molecules together with the CD3 complex promotes T cell activation.
In contrast to the AC requirement for soluble anti-CD3 induced T cell activation, T4 cell proliferation can be stimulated in the complete absence of AC when the anti-CD3 is immobilized onto a polystyrene surface (6) . The response is directly related to the density and the nature of the immobilized anti-CD3. Thus, a high density of one of the anti-CD3 MAb, 64.1, induces vigorous proliferation that is not enhanced by accessory cell signals, whereas lower densities of 64.1 induce suboptimal T4 cell responses that can be enhanced by auxiliary influences. Responses induced by still lower densities of 64.1 are completely dependent on additional signals (6) . These findings suggest a model wherein maximal anti-CD3 induced T4 cell activation requires multiple interactions with CD3. When the stimulus is suboptimal, responses are dependent on signals provided by AC or MAb that deliver AC like signals. The mechanism whereby AC promote responses induced by suboptimal stimulae is unclear.
These studies were undertaken to determine whether immobilized MAb to other T4 cell surface molecules might simulate some AC-T cell interactions and enhance T4 cell proliferation induced by suboptimal stimulation via the CD3 molecule. To investigate this possibility, highly purified T4 cells depleted of all AC were used as the responding cells and the effects of immobilized and soluble MAb directed at various T cell surface molecules including CDl la (LFA-1), CD2, CD4, CD5, CD28 (Tp44), and class I MHC encoded gene products were examined. MAb directed at these antigens were chosen because it has been suggested that these determinants may be involved in accessory cell-T cell interactions (5, (7) (8) (9) (10) (11) (12) T cell purification. T cells were prepared from PBM as previously described (22) . Briefly, PBM were incubated with 5 mM L-leucine methyl ester HCI (Sigma Chemical Co., St. Louis, MO) to remove contaminating MO (23 synthesis. The effect of soluble or immobilized MAb directed at various non-CD3 T4 cell surface proteins was examined. As shown in Fig. 1 , low density immobilized OKT3 induced minimal proliferation of AC-depleted T4 cells. The response was not effected by soluble control MAb but was markedly enhanced by soluble 9.3 (anti-CD28). Soluble 60.3 (anti-LFA-1), MB40.5 (anti-HLA-A,B,C), and OKT1 1 (anti-CD2) did not enhance or inhibit the response. When immobilized, the MAb to LFA-1, CD2 and HLA-A,B,C dramatically enhanced T4 cell proliferation induced by immobilized OKT3. Other anti-HLA-A,B,C MAb, including W6/32 and PA2.6 and the anti-CD2 MAb, 9.6, gave similar results (data not shown). Maximal proliferation was comparable when MAb to CD2, LFA-1 or class I MHC molecules were employed. However, to obtain comparable enhancement of immobilized OKT3 induced responses, 10-fold greater concentrations of MB40.5 (anti-HLA-A,B,C) than 60.3 (anti-LFA-l) or OKT1 1 (anti-CD2) were required. In the absence of anti-CD3, none of the immobilized MAb induced T4 cell proliferation (6) . Immobilized 9.3 also enhanced the response, but was not a more effective promoter of immobilized OKT3 induced T4 cell proliferation than soluble 9.3. Moreover, immobilized 9.3 was a less effective promoter of immobilized OKT3 induced T4 cell proliferation than immobilized 60.3, MB40. hanced responses somewhat less effectively than immobilized MAb to CD2. Similar results were obtained when the amplifying capacity of anti-CD4 was compared to that of anti-HLA-A,B,C or anti-LFA-l (data not shown).
Immobilized MAb directed at CD2, LFA-J or HLA-A,B,C enhance suboptimal but not maximal proliferation induced by anti-CD3. As previously noted (6), high density immobilized 64.1 stimulates all T4 cells to enter the cell cycle, whereas, low density immobilized 64.1 and all densities of OKT3 stimulate submaximal responses. Table II The capacity ofMAb to various T cell surface molecules to enhance immobilized anti-CD3 induced T4 cell proliferation when the MAb to CD3 and the additional T cell surface molecules are immobilized onto different surfaces. The capacity of MAb to various T cell surface molecules to enhance anti-CD3 induced T4 cell proliferation when the additional MAb and the Immobilized anti-CD3 MAb must be present throughout the culture period for optimal proliferation and IL-2 responsiveness. The experiments depicted in Fig. 2 
Discussion
These studies examined the effect of MAb directed at various T cell surface proteins on the capacity of immobilized anti-CD3 to induce T4 cell proliferation in the absence of AC. Optimal proliferation induced by high density 64.1 was unaffected by the soluble or immobilized MAb used in these stud- The capacity of MAb to T cell surface molecules to enhance immobilized anti-CD3 induced responses has been examined previously (27) (28) (29) (30) . In contrast to the current studies, however, the previous reports were only able to detect responses in cultures containing intact AC or supplemental IL-2. The current studies are the first in which T cell proliferation could be detected in the complete absence ofAC or exogenous IL-2. These experiments, therefore, unambiguously delineate the signals that are necessary to induce T cell proliferation and not merely IL-2 responsiveness, since the cultures contain no other cell types. The capacity to induce proliferation and IL-2 responsiveness in the absence of AC relates to the use of MAb immobilized to polystyrene microtiter wells, which appear to have the capacity to bind a much greater density of MAb than more standard solid supports such as Sepharose or polystyrene beads. Previous studies have focused on the capacity of MAb to CD4, CD2, CD5, CD6, and CD8 to induce IL-2 responsiveness of anti-CD3 stimulated T cells (27) (28) (29) (30) . The current studies greatly expand upon this background and document that MAb to class I MHC molecules and LFA-1 are also able to enhance anti-CD3 induced T4 cell proliferation. The costimulatory potency of anti-HLA-A,B,C and anti-LFA-1 was comparable to that of anti-CD2 and much greater than that of anti-CD4.
It is possible from the data obtained in the current and previous studies to create a hierarchy relating the capacity of the MAb to various T cell surface antigens to enhance immobilized anti-CD3 induced responses. Walker et al. demonstrated that the capacity of the MAb to enhance immobilized anti-CD3 induced responses depended on the molecule recognized by the MAb and not the epitope recognized by the MAb or the isotype of the MAb (30) . Thus, responses were most effectively promoted by MAb to CD2 followed by MAb to CD5, CD6, and CD4 in descending order ofpotency. Whereas the capacity of MAb to CD6 to enhance immobilized anti-CD3 induced T cell proliferation was not examined in the current study, the enhancement induced by anti-CD2 was found to be greater than that induced by anti-CD4 as previously observed, despite the use of different MAb and different techniques of immobilizing the MAb. The current studies expand the previous observations by demonstrating that MAb to class I MHC molecules and LFA-l are as effective as MAb to CD2 at enhancing anti-CD3 induced responses, whereas each is more effective than MAb to CD4, CD5, and CD28. This hierarchy has important implications. Anderson et al. (28, 29) and Emmrich et al. (28, 29) have used the capacity of immobilized MAb to CD4 to enhance anti-CD3 induced T cell IL-2 responsiveness to suggest that cross-linking of the T cell receptor/CD3 complex with CD4/8 is essential for T cell activation. If this reasoning is correct, the current findings and those of Walker et al. (30) would suggest that cross-linking CD3 with CD2 or LFA-l may also be necessary and perhaps more important for T cell activation. Alternatively, the data suggest that cross-linking any one of a variety of T cell surface molecules to the T cell receptor/CD3 complex is sufficient to induce T cell activation when signaling via CD3 is suboptimal, although no such cross-linking is necessary when adequate triggering through CD3 occurs. Finally, the results with the MAb to class I MHC molecules indicate that costimulation of T4 cells can also be achieved when separate signals are delivered. Thus, the finding that costimulation was noted when T4 cells were cultured with MAb to CD3 and HLA-A,B,C immobilized to separate matrices indicates that in this circumstance T4 cell activation is unlikely to require cross-linking of the T cell receptor/CD3 complexes to class I MHC molecules but rather results from the summation of separate signals generated when each of these molecules is cross-linked.
The mechanism whereby a second immobilized MAb enhances immobilized anti-CD3 induced T4 cell activation has not been delineated. One possibility is that the additional immobilized MAb serves to bind the T4 cell to the plastic microtiter well and thereby stabilizes the interaction between the CD3 molecule on the T4 cell and the immobilized anti-CD3 MAb. This conclusion is supported by the observation that enhancement was most marked when T4 cells were stimulated simultaneously with OKT3 and the additional immobilized MAb. This hypothesis is favored by Walker et al. (30) . The authors support this claim with the observation that immobilized MAb to CD2, CD4, CD5, CD6, and CD8 did not enhance immobilized anti-CD3 induced IL-2 responsiveness when the MAb were immobilized to distinct surfaces. The finding that immobilized MAb to CD2 and CD4 do not enhance immobilized OKT3 induced responses when the MAb are immobilized onto different surfaces in the current studies confirms these findings. The current findings expand these observations by demonstrating that MAb to CD1 la also do not enhance responses when immobilized onto a different surface. More importantly, however, the current findings demonstrate that immobilized MAb to class I MHC molecules do enhance immobilized OKT3 induced T4 cell proliferation when the MAb are immobilized onto different surfaces. These results demonstrate that MAb to class I MHC antigens enhance responses by a mechanism other than stabilizing the interaction between CD3 and anti-CD3 and support the conclusion that the interaction between class I MHC antigens and the immobilized MAb results in the generation of a signal that promotes T cell activation. These data indicate that MAb to class I MHC molecules differ from MAb to CD2, CD4, CD5, CD6, CD8, and CDl la in that they do not costimulate by cross-linking the molecule recognized with CD3, but rather deliver a separate and distinct signal to T4 cells that can enhance activation and proliferation.
Several findings support the hypothesis that each of the immobilized MAb utilized augment anti-CD3 stimulated responses by delivering signals that promote T cell activation and not merely by binding the T cells to the microtiter wells and thereby facilitating interactions between CD3 and anti-CD3. First, in the studies by Walker et al. (30) and in the current studies, there was no correlation between the capacity of a MAb to augment anti-CD3 stimulated T cell proliferation or IL-2 responsiveness and the density ofthe recognized determinant, the epitope recognized by the MAb or the isotype of the MAb. Thus, in the current studies, immobilized anti-CD4 and anti-CD5 only enhanced responses modestly, although there is a high density ofCD4 and CD5 molecules on the T cell surface (data not shown). Moreover, a 10-fold greater amount of anti-HLA-A,B,C compared to anti-CD2 was necessary to achieve comparable enhancement of immobilized OKT3 induced T4 cell proliferation despite the observation that the density of class I MHC encoded gene products on T4 cells is greater than the density of CD2 (data not shown (37) . Anti-HLA-A,B,C antibodies did not inhibit T cell proliferation induced by AC-independent stimuli such as the combination of OKT3 and phorbol myristate acetate (5). These results are consistent with the conclusion that AC-T cell interactions mediated by class I MHC antigens play a role in activating T cells. The current data indicate that these AC-T cell interactions can be simulated by immobilized MAb to HLA-A,B,C. Moreover, the findings suggest that cross-linking of class I MHC molecules delivers an independent signal that can enhance proliferation of T4 cells stimulated by immobilized anti-CD3. More recent studies have supported this conclusion by demonstrating that MAb to class I MHC molecules stimulate a rise in intracellular free calcium in highly purified T4 cells when cross-linked (Geppert, T. D., M. C. Wacholtz, L. S. Davis, and P. E. Lipsky, manuscript submitted for publication). These observations suggest that class I MHC molecules have the capacity to transmit activation signals to T4 cells when cross-linked and support the conclusion that the enhancement of anti-CD3 induced proliferation by MAb to HLA-A,B,C results from the provision of an additional activation signal.
It is clear from previous studies that LFA-l promotes cellular adhesion in a number of model systems (38, 39) . T cell functions that are dependent on cellular interactions including antigen-, alloantigen-, and mitogen-induced T cell proliferation and cytotoxicity are inhibited by MAb to LFA-1 (7). The capacity of immobilized 60.3 to enhance immobilized OKT3-induced proliferation suggests that interactions involving LFA-I may also deliver signals to the T4 cell that promote anti-CD3-induced T4 cell activation. Thus, one function of LFA-1, in addition to its role in cellular adhesion, may be to transmit regulatory signals. Previous work has demonstrated that a MAb to LFA-I promotes murine B cell activation (40) . In a similar manner, 60.3 may promote human T4 cell activation by delivering a signal that facilitates proliferation induced by suboptimal stimulation via the CD3 pathway.
Previous studies have reported that CD4 plays a role in regulating T4 cell function. Thus, anti-CD4 has been shown to inhibit antigen-, alloantigen-, and mitogen-induced T4 cell proliferation (5, 8, 10) . In contrast to MAb directed at CD2 and LFA-1, anti-CD4 MAb have also been demonstrated to inhibit accessory cell independent T4 cell proliferation induced by immobilized anti-CD3 (6, 41) . This finding has suggested that anti-CD4 may directly suppress T4 cell activation. The findings presented here, that soluble anti-CD4 inhibits anti-CD3 stimulated T4 cell proliferation, are in agreement with these earlier observations and demonstrate that interactions with CD4 can directly suppress T4 cell responses. The capacity ofanti-CD4 to inhibit T4 cell responsiveness has been found to vary with the intensity ofthe activation signal (6) . Thus, T4 cell proliferation and IL-2 production induced by high density anti-CD3 were only modestly inhibited by soluble anti-CD4, whereas that stimulated by low density anti-CD3 was inhibited to a much greater degree. In contrast to the capacity of soluble anti-CD4 to inhibit, immobilized anti-CD4 enhanced immobilized OKT3-induced proliferation. These results are consistent with previous findings that cross-linking CD3 and CD4 can induce IL-2 responsiveness (28) (29) (30) . Therefore, MAb directed at CD4 can transmit both negative and positive effects to T4 cells. The current studies differ from previous reports (28 -30) 
